An impressive array of evidence has been obtained during the past decade establishing correlations between specific DNA adducts and carcinogenesis. Many of the studies utilized organ specific differences in carcinogenesis to establish the correlations. More recently, we have investigated similar relationships between target and nontarget cell populations within the liver. Chronic exposure to methylating hepatocarcinogens predominantly induces hemangiosarcomas, whereas exposure to ethylating agents causes hepatocellular carcinomas. This cell specificity in carcinogenesis correlates well with the presence of promutagenic DNA adducts. In the case of methylating agents, the nonparenchymal cells accumulate o6-methylguanine whereas the hepatocytes do not. Exposure to ethylating agents leads to accumulation of O'-ethyldeoxythymidine, but not 06-ethyldeoxyguanosine in hepatocytes. These differences reflect the ability of the two cell populations to repair 06-alkylguanine and the extent of purine and pyrimidine alkylation with methylating and ethylating agents. Hepatocytes of rats exposed to diethylnitrosamine for 28 days have four to five times more promutagenic DNA adducts (06-alkyldeoxyguanosine and 04-alkyldeoxythymidine) than hepatocytes of rats exposed to nearly equimolar doses of dimethylhydrazine. Both 06-methylguanine and 04-methyldeoxythymidine are rapidly repaired by rat hepatocytes, while only o6-ethyldeoxyguanosine is rapidly repaired. Studies comparing the relationship between the induction of -yglutamyl transpeptidase-positive foci, hepatocellular carcinoma and promutagenic lesions such as 04-ethyldeoxythymidine will be useful in understanding associations between the molecular dosimetry of DNA adducts, initiation, and progression of hepatocarcinogenesis.
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During the past (14) .
into nonparenchymal cells (NPC), consisting of endothelial and Kupffer cells, and hepatocytes by either centrifugal elutriation (13, 16) or low-speed centrifugation (14, 17, 18) .
Exposure of F-344 rats to drinking water containing 30 ppm SDMH resulted in similar concentrations of 7-methylguanine (7-MG) in both NPC and hepatocytes ( Fig. 1) The marked difference in 06-MG concentrations between NPC and hepatocytes was due to differences between the two cell populations in both the constitutive amount and the inducibility of the DNA repair enzyme, 06-methylguanine DNA methyltransferase (06-MGMT). Control hepatocytes were shown to have -5 times more 06-MGMT per cell than NPC (19) . Furthermore, the 06_ MGMT activity in hepatocytes was induced during exposure to SDMH. This induction correlated with the rapid decrease in 06-MG concentrations in hepatocytes. In contrast, the 06-MGMT activity in NPC was depleted during the initial 3-4 days of SDMH exposure, after which it returned to constitutive levels. Accordingly, the rapid accumulation of 06-MG in NPC corresponded with the depletion of 06-MGMT, while the subsequent decline in 06-MGMT corresponded with the return of 06-MG to constitutive levels.
Parallel investigations on de novo DNA synthesis demonstrated that the NPC underwent a marked mitogenic stimulus during SDMH exposure (20) . Hepatocytes also showed increased cell replication; however, the extent was much less. If one examines the product of cell replication x the concentration of 06-MG during SDMH exposure and normalizes this with the amount of DNA per cell population, the area under each curve represents the theoretical probability of initiation per liver due to 06-MG (Fig. 2) (21) . Using this calculation, the probability of inducing angiosarcomas is 17-fold greater than that of hepatocellular carcinomas. Furthermore, the predicted probability of hepatocellular carcinoma induction is highest in the first 4 days of SDMH exposure. A bioassay using the same dosing regimen demonstrated that angiosarcomas were induced in 93% of the rats, while hepatocellular carcinomas were produced in 40% of the animals (13) . Thus, this model for initiation underestimated the latter, suggesting that DNA adducts other than 06-MG might be involved. As will be discussed in greater detail in subsequent portions of this review, it is likely that 04-methyldeoxythymidine also contributes to the initiation of hepatocytes (18) .
Studies also have been conducted on C3H mice exposed to DMN (14) . The NPC progressively accumulated 06-MG over 32 days of exposure to 10 ppm DMN, reaching -50 pmole/mg DNA (Fig. 3) . In contrast, the hepatocytes maintained constant amounts of 06-MG (-5 pmole/mg DNA) throughout the exposure regimen.
Both cell populations exhibited a 2-to 3-fold increase in de novo DNA synthesis during the 32-day period of exposure to DMN. When these data were used to pre- dict the likelihood of initiation due to 06-MG, the target cells (NPC) were predicted to be 2.5 times more likely to be initiated during the 32-day exposure than the hepatocytes, a finding in general agreement with several bioassays. Similar methods were used to investigate the mechanisms of hepatocellular carcinoma induction by DEN. Initial studies using fluorescence detection for 06-ethylguanine (06-EG) were hampered by concentrations of 06-EG too low to be detected by this method (22) . Since 06-EG is known to be repaired in a manner similar to 06-MG, it was postulated that most initiation due to O6-EG would occur during the first 1 to 2 weeks of exposure. Therefore, if hepatocellular carcinoma induction by DEN was primarily due to 06-EG, initiation also should occur primarily during the first 2 weeks of exposure. This was tested by exposing rats to 40 ppm DEN in their drinking water for up to 10 weeks, followed by placing the animals on the Solt-Farber selection regimen for GGT + foci (12) . The data in Figure 4 clearly demonstrate that initiation was not confined to the first 2 weeks. Rather, the number of GGT + foci remained similar to controls during the first 2 weeks and then progressively increased with increasing length of exposure. These data strongly suggested that DNA adducts other than 06-EG were responsible for hepatocellular carcinoma induction.
In (Fig. 6) (12) . These animals were much more sensitive to the induction of GGT + foci and hepatocellular carcinoma. Since the molecular dosimetry of 4-and 8-weekold rats was similar, this increased susceptibility most likely reflects increased cell proliferation associated with the rapid growth of these younger animals (12) .
As shown in Figure 6 , GGT + foci appeared earlier and in greater number in 4-week-old rats, than in 8-week-old rats (Fig. 4)(12) . Of greater interest was the demonstration that the number of foci per cubic centimeter plateaued. Since foci are believed to represent initiation of hepatocytes, which is a cumulative event, this was unexpected. The most likely interpretation of these data is that the plateau represents a steady state, during which initiated cells are being formed at a rate similar to that of their loss. Loss could be the result of a change in phenotype or cell death at the single cell stage of focus development.
Polyclonal antibodies to 04-methylthymidine (04-MedThd) were also developed, permitting the first measurements of this minor alkylation product in animals exposed to methylating agents (18) . Following a single 20 mg/kg exposure to SDMH, 04-MedThd was present in rat liver at 1/100 the amount of 06-MG. 04-MedThd was removed from rat liver relatively rapidly, having a half-time of -20 hr (Fig. 7) . In contrast, 04-EtdThd had a half-time of -11 days, whether it was formed by a single exposure to 15 mg/kg DEN or by continuous exposure to 40 ppm DEN in the drinking water for 4 weeks. No evidence for an inducible repair system for 04-EtdThd was demonstrable. Thus, differences in repair rates of 04-MedThd and 04-EtdThd provides a mechanism to explain the greater ability of ethylating versus methylating agents to induce hepatocellular carcinoma in the rat. This is shown in Table 1 , where alkylation data from hepatocyte DNA of rats exposed to equimolar doses of SDMH and DEN for up to 28 days were compared (18) 
Potential of Molecular Dosimetry in Risk Assessment
The field of risk assessment is rapidly changing from presenting qualitative risk assessments to making quantitative estimates of risk. Numerous mathematical models have been developed, ranging from linear extrapolation based on a one-hit one-cancer theory, to present day multistage and multihit models thought to better approximate the steps involved in carcinogenesis. A critical problem is that the accuracy of these models can not be validated with bioassay data. Data from the ED,, study, which involved exposure of 24,192 mice to 2-acetylaminofluorene, have been used but are woefully inadequate for low-dose extrapolation, since the dose range employed covered less than one order of magnitude (23) . This study points out the futility of conducting animal bioassays to validate true low dose extrapolations (four to six orders of magnitude), since millions of animals would be required to detect a response at such extremely low doses. An alternative method using molecular dosimetry as the measure of exposure followed by an examination of tumor incidence relative to DNA adducts has been suggested. Present-day models for quantitative risk assessment use measures of external exposure such as ppm in air, water, or diet. Such measures of exposure cannot account for nonlinearities in the dose response (24, 25) . The schematic shown in Figure 8 shows some of the possible fates of external exposure. Absorption of a chemical can range from 0 to 100%, yielding the internal exposure or dose. This internal dose can be metabolized to an activated or a detoxified form, again ranging from 0 to 100%, yielding the internal activated dose. This dose is distributed to critical and noncritical sites. By measuring the dose at target sites, one should have the most 
